Case presentation: a severe case of cobalamin c deficiency presenting with nephrotic syndrome, malignant hypertension and hemolytic anemia.
MMACHC
Cobalamin C deficiency
Hemolytic anemia
Inborn errors of metabolism
Nephritic syndrome
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
08 Jul 2024
08 Jul 2024
Historique:
received:
28
10
2023
accepted:
26
06
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
8
7
2024
Statut:
epublish
Résumé
The etiology of nephrotic syndrome can vary, with underlying metabolic diseases being a potential factor. Cobalamin C (cblC) defect is an autosomal recessive inborn error of metabolism caused by mutations in the MMACHC gene, resulting in impaired vitamin B12 processing. While cblC defect typically manifests with hematological and neurological symptoms, renal involvement is increasingly recognized but remains rare. We describe a 7-month-old male patient presenting with fatigue and edema. His first laboratory findings showed anemia, thrombocytopenia, hypoalbuminemia and proteinuria and further examinations reveals hemolysis in peripheric blood smear. During his follow up respiratory distress due to pleural effusion in the right hemithorax was noticed. And fluid leakage to the third spaces supported nephrotic syndrome diagnosis. The patient's condition deteriorated, leading to intensive care admission due to, hypertensive crisis, and respiratory distress. High total plasma homocysteine and low methionine levels raised suspicion of cobalamin metabolism disorders. Genetic testing confirmed biallelic MMACHC gene mutations, establishing the diagnosis of cblC defect. Treatment with hydroxycobalamin, folic acid, and betaine led to remarkable clinical improvement. This case underscores the significance of recognizing metabolic disorders like cblC defect in atypical presentations of nephrotic syndrome. Early diagnosis and comprehensive management are vital to prevent irreversible renal damage. While cblC defects are more commonly associated with atypical hemolytic uremic syndrome, this case highlights the importance of considering cobalamin defects in the differential diagnosis of nephrotic syndrome, especially when associated with accompanying findings such as hemolysis. Our case, which has one of the highest homocysteine levels reported in the literature, emphasizes this situation again.
Sections du résumé
BACKGROUND
BACKGROUND
The etiology of nephrotic syndrome can vary, with underlying metabolic diseases being a potential factor. Cobalamin C (cblC) defect is an autosomal recessive inborn error of metabolism caused by mutations in the MMACHC gene, resulting in impaired vitamin B12 processing. While cblC defect typically manifests with hematological and neurological symptoms, renal involvement is increasingly recognized but remains rare.
CASE PRESENTATION
METHODS
We describe a 7-month-old male patient presenting with fatigue and edema. His first laboratory findings showed anemia, thrombocytopenia, hypoalbuminemia and proteinuria and further examinations reveals hemolysis in peripheric blood smear. During his follow up respiratory distress due to pleural effusion in the right hemithorax was noticed. And fluid leakage to the third spaces supported nephrotic syndrome diagnosis. The patient's condition deteriorated, leading to intensive care admission due to, hypertensive crisis, and respiratory distress. High total plasma homocysteine and low methionine levels raised suspicion of cobalamin metabolism disorders. Genetic testing confirmed biallelic MMACHC gene mutations, establishing the diagnosis of cblC defect. Treatment with hydroxycobalamin, folic acid, and betaine led to remarkable clinical improvement.
DISCUSSION/CONCLUSION
CONCLUSIONS
This case underscores the significance of recognizing metabolic disorders like cblC defect in atypical presentations of nephrotic syndrome. Early diagnosis and comprehensive management are vital to prevent irreversible renal damage. While cblC defects are more commonly associated with atypical hemolytic uremic syndrome, this case highlights the importance of considering cobalamin defects in the differential diagnosis of nephrotic syndrome, especially when associated with accompanying findings such as hemolysis. Our case, which has one of the highest homocysteine levels reported in the literature, emphasizes this situation again.
Identifiants
pubmed: 38977946
doi: 10.1186/s12882-024-03656-1
pii: 10.1186/s12882-024-03656-1
doi:
Substances chimiques
Oxidoreductases
EC 1.-
Vitamin B 12
P6YC3EG204
Carrier Proteins
0
MMACHC protein, human
EC 1.-
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
217Informations de copyright
© 2024. The Author(s).
Références
Hampson KJ, Gay ML, Band ME. Pediatric nephrotic syndrome: pharmacologic and nutrition management. Nutr Clin Pract. 2021;36(2):331–43.
doi: 10.1002/ncp.10622
pubmed: 33469930
Semwal M. A review on nephrotic syndrome with their causes, complications and epidemiology. Asian Pac J Nurs Health Sci. 2020;3(1):12–5.
Lane JC, Kaskel FJ. Pediatric nephrotic syndrome: from the simple to the complex. In seminars in nephrology. Elsevier; 2009.
Welegerima Y, Feyissa M, Nedi T. Treatment outcomes of pediatric nephrotic syndrome patients treated in Ayder Comprehensive Specialized and Mekelle General Hospitals, Ethiopia. Int J Nephrol Renovascular Disease, 2021: p. 149–56.
Lemoine M, Grangé S, Guerrot D. Kidney disease in cobalamin C deficiency. Volume 15. Néphrologie & Thérapeutique; 2019. pp. 201–14. 4.
Liu X, et al. Prominent renal complications associated with MMACHC pathogenic variant c. 80A > G in Chinese children with cobalamin C deficiency. Front Pead. 2023;10:1057594.
doi: 10.3389/fped.2022.1057594
Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis. 2011;34:127–35.
doi: 10.1007/s10545-010-9161-z
pubmed: 20632110
Ceravolo F, et al. Pathobiological insights into neurological involvement in Cobalamin C Deficiency. J Pediatr Biochem. 2016;6(01):025–9.
doi: 10.1055/s-0036-1582251
McCully KS. Hyperhomocysteinemia and arteriosclerosis: historical perspectives. Clin Chem Lab Med (CCLM). 2005;43(10):980–6.
doi: 10.1515/CCLM.2005.172
pubmed: 16197285
Wood WD et al. The roles of homocysteinemia and methylmalonic acidemia in kidney injury in atypical hemolytic uremic syndrome caused by cobalamin C deficiency Pediatric Nephrology, 2021: pp. 1–4.
Weisfeld-Adams JD, et al. Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance. Mol Genet Metab. 2015;114(4):537–46.
doi: 10.1016/j.ymgme.2015.01.012
pubmed: 25742969
Wang X, et al. Distinct clinical, neuroimaging and genetic profiles of late-onset cobalamin C defects (cb1C): a report of 16 Chinese cases. Orphanet J Rare Dis. 2019;14:1–9.
doi: 10.1186/s13023-019-1058-9
Kacpura A, et al. Clinical and biochemical outcomes in cobalamin C deficiency with use of high-dose hydroxocobalamin in the early neonatal period. Am J Med Genet Part A. 2022;188(6):1831–5.
doi: 10.1002/ajmg.a.62687
pubmed: 35156754
Topaloglu R, et al. Do not miss rare and treatable cause of early-onset hemolytic uremic syndrome: cobalamin C deficiency. Nephron. 2019;142(3):258–63.
doi: 10.1159/000497822
pubmed: 31137025
ÖZTÜRK HİŞMİ B. and H. ALPAY, Son dönem böbrek yetmezliğine ilerleyen bir sekonder HÜS nedeni: Kobalamin defekti 2021.
Matos IV, et al. Clinical and biochemical outcome after hydroxocobalamin dose escalation in a series of patients with cobalamin C deficiency. Mol Genet Metab. 2013;109(4):360–5.
doi: 10.1016/j.ymgme.2013.05.007
pubmed: 23746552